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Abstract: 
4-thiazolidinones are among t h e  mos t  ex tens ively inves t igated  c lass o f  organic compounds. Thiazolidin-4-one has 
been considered as magic moiety, which is a core  structure  in  various  synthetic  pharmaceuticals  displaying  a broad 
spectrum  of  biological   activities.They are widely used as  anti-inflammatory, anticonvulsant, analgesic, 
antimicrobial,anti-HIV,CNS depressant, carcinostatic, antihypertensive and cytotoxic. In view of the wide spectrum 
activities of condensed 4-thiazolidinones, it was thought worthwhile to undertake the synthesis of heterocyclic systems in 
which 4-thiazolidinone nucleus is linked to another biologically active moiety.Semicarbazide/Thiosemicarbazide was 
reacted with b e n z o y l  chloride to obtain N-hydrazinocarbonyl benzene-1-carboxamide/N-hydrazinocarbothioylbenzene-1 
carboxamide respectively.These were then condensed with various aldehydes to yield the intermediate Schiff bases. 
Thiazolidin-4-ones were prepared by the reaction of Schiff bases with mercaptoacetic acid in dry benzene by refluxing for 
16-18 hours. 
The purity of the compounds synthesized was established by TLC.The synthes i z ed  derivatives were character i z ed  
by  FT-IR,1HNMR and Mass spectral analysis. All the derivatives synthesized were screened for their anti-bacterial and 
antifungal activities using cup-plate method against Bacillus subtilis, Salmonella typhi, Escherichia coli, Staphylococcus 
aureus, Aspergillus niger and Candida albicans at 100µ g/ml using ciprofloxacin and clotrimazole as reference standard 
drugs respectively.The  compounds belonging to series (3A1-3A6) have shown promising antibacterial and antifungal  
activity and those belonging to series (3B1-3B6)  were  moderate  compared  to  standard. 
The antimicrobial activity data reveals that, the compounds bearing the phenyl carbonyl urea in their structure, were 
found to be more potent than the phenyl carbonyl thiourea containing derivatives, indicating the influence of oxygen in 
enhancing the antimicrobial potency. 
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INTRODUCTION: 
The history of 4- thiazolidinone can be traced back 
to the early work on thiazoles. (1) 
 
                                                                                                  
N
S
 
                                                                              
1 
 
Compound containing a simple thiazole 
nucleuses were first reported by Hantzch[1]
  
in a 
series of paper beginning from 1887. After this 
pioneering work, knowledge of the thiazole 
system developed shortly. Many thiazole 
derivatives were found to have biological and 
commercial interest. Green[2] in 1888 described 
a yellow primuline base and dihydro-thio-p-
toludine. These were obtained by fusion of p-
toludine with sulfur. These compounds were 
recognized as benzothiazole derivatives. 
Subsequently many related compound were 
prepared. 
In 1935, Williams et  al [3]demonstrated the  
existence of  a  simple  thiazole moiety in the 
structure of Vitamin B1 (2).It was combined with 
4-thiazolidinone with a view to increase the 
antibacterial activity [4]. 
The  historical  importance  of  thiazole  
derivatives  was  further  emphasized during the 
period 1941-45, when work on the structure of 
penicillins (3) showed the thazolidine ring in it. 
The occurrence of thiazole derivative in nature 
was reported in 1952 when actithiazic acid (4), 
an antibiotic was found to be a 4-
thiazolidinone derivative[5,6].
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Thiazolidinones[7,8]
 
are  derivatives  of thiazolidine,which belongs  to  an  important group of heterocyclic 
compounds.Thiazolidinones with a carbonyl group at position 2,4 or 5 have been subject of extensive study 
in recent years [9-14]. 
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In recent years,   4-thiazolidinones   and   2,4-
thiazolidinediones   have   been among  the  most 
extensively investigated classes of organic 
compounds.  
Thiazolidine der i va t i ves  a r e  r ep or t ed  t o  
s h ow a  variety of bi ol og i ca l  a c t i vi t i e s . 
 The presence of a thiazolidine ring in penicillin 
and related derivatives was the first recognition of 
its occurrence in nature[15].Thiazolidine-4-one 
represents a prevalent scaffold in  drug  discovery 
[16]
 
. Thiazolidine-4-ones  have many  interesting 
activity  profiles,  namely  COX-1inhibitors[17]
, 
inhibitors  of  the  bacterial  enzyme MurB,  
which  was  a  precursor  acting  during  the 
biosynthesis of  peptidoglycan[18], non-nucleoside 
inhibitors of HIV-RT [19]
 
and anti-histaminic 
agents[20]. Thiazolidinones has be e n  considered 
as magic moiety (wonder nucleus), which is a 
core s t r u ct u r e  in various synthetic 
pharmaceuticals displaying a broad spectrum 
biological activities [21-23]. 
Condensed 4-thiazolidinones have received  
interest and  attention  from  a large number  of 
organic chemists,  pharmacologists  and  biologists  
world over , on account of significant threupetic 
and  other properties associated with thiazolidinone   
nucleus.Applications of 4-thiazolidinones are 
manifold and versatile. 
They are Widely Used As anticonvulsant [24], 
antimicrobial [25],anti-inflammatory [26], 
antihypertensive [27],hypnotic [28],antidiabetic 
[29],antifungal [30],antibacterial [31],antitumor[ 
32],anti-HIV [33],antiviral [34],anticancer 
[35],cardiotonic [36]
, 
antitubercular [37], etc. 
Condensed 4-thiazolidinones have also found 
applications in the synthesis of cyanine and 
merocyanine dyes and it has been reported that the 
introduction of arylidene moieties at different 
positions of the thiazolidinone ring enhanced 
biological activity [38-40]. Some authors examined 
the ability of this ligand structure to form 
complexes with some radionuclides for potential use 
in nuclear medicine [41]. 
 
 OBJECTIVES 
The  search  for  an  ideal  chemotherapeutic  
agent  has  began  long  ago. Molecular 
modification  of  a  promising  lead  compound  is  
still  a  major line  of approach for the discovery   
of new drug.  
Molecular modification involves substituting, 
eliminating, or  adding  new  moieties  to  a  
parent  lead  compound, there by  making  gradual  
changes  in  the  structure  of  the  compound 
resulting  in gradual changes  in  the  physico-
chemical  properties  of  the  parent  compound  
and thus biological  activity  of  the  compound. It  
is  clear  from  the  literature  review that  a 
number  of  substituted  thiazolidinones  
derivatives  are  known   to   posse’s antituberculor,    
analgesic,anti-microbial,anti 
HIV,anticonvusant,antifungal activities. It has been 
reported tha t  t h i a z o l i d i n on e s  a l so poss e s s  
an al ges i c ,  an t i - inflammatory a n d  
a n t i m i c r o b i a l  activities. 
Thiazolidinones are of  g r ea t  i n t er e s t  due  t o  
t h e i r  excep t i on al  bi ol og i ca l  activity. The 
treatment of pain continues to be the subject of 
considerable Pharmaceutical and clinical  
research in recent year s. A  systematic  
investigation of this class of heterocycle  revealed  
that  thiazolidinones containing pharmacoactive 
agent  play important  role  in  medicinal  
chemistry.Chemotherapeutic analgesic and anti 
inflammatory drugs are prescribed simultaneously 
in normal practice. 
By considering the above factors, in the present 
investigation it was planned to undertake the 
research work as below: 
1. To  synthesize  some  of  the thiazolidin-4-
one  derivatives  and  to characterize the  
new   compounds  by  analytical  spectral  
methods  viz,Infrared (IR),  Mass spectra  
and Nuclear  Magnetic Resonance (NMR). 
2.  To assess the acute toxicity of the derivatives                              
         synthesized following (OECD Guidelines -      
          420). 
3.  To screen few of the derivatives for their 
analgesic activities using Eddy’s hot plate 
method. 
4.  To  screen  few  of  the  derivatives  for  their   
     anti-inflammatory  activities  using 
      Carrageenan induced rat  paw edema method. 
  
METHODOLOGY: 
The importance of thiazolidin-4-one moiety has 
been discussed in the previous chapter. Among   the  
many  methods  available  for  the  synthesis of 
thiazolidinone derivatives , in  the  present  
chapter  a convenient  and  versatile  methodology  
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has been  adopted  for  the synthesis of thiazolidin-
4-one derivatives.In the present case 
semicarbazide/Thiosemicarbazide  was reacted with 
benzoyl  chloride  to  obtain  N- 
hydrazinocarbonylbenzene-1-carboxamide/N-
hydrazinocarbothioylbenzene-1 carboxamide 
respectively.These were  then  condensed  with  
various aldehydes to yield  the intermediate Schiff 
bases. Thiazolidin-4-ones were prepared by the 
reaction of Schiff bases with mercaptoacetic acid 
in dry benzene by refluxing for 16-18.hrs. 
All the reactions were carried out under 
prescribed laboratory conditions and we are 
monitored by TLC technique using Precoated 
TLC plates .The products were purified by 
recrystallization. Melting points were determined 
by capillary method and were uncorrected. 
1
HNMR spectra of the final compounds were 
recorded on Bruker Avance II 300 NMR 
spectrometer (300 MHZ).  All spectra were 
obtained in a mixture of DMSO. Furtherevidence 
about the structure was obtained by   
recording   the mass spectrum of few typical 
compounds, along with their IR spectra and 
1
HNMR. 
Material and Methods 
a)  The entire chemicals used were 
procured from Qualingens, Himedia 
and Loba- chemicals.   Purity o f  
star ting materials  used for  
r eact ion  was con fi rm ed  by 
checking their melting point or boiling 
point and by thin layer chromatography. 
b)  Melting points were determined in 
open capillary tube using precision 
melting point apparatus and 
uncorrected. 
c)  The FT-IR a spectra of the synthesized 
compounds has been obtained from 
NGSM Institute of  Medical Sciences 
Deralakatte, Mangalore. The IR 
spectra were carried out by 
SHIMADZU  PERKIN EKMER 8201 
PC IR SPECTROMETER using a thin 
film on potassium bromide pellets. 
d)  The 
1
HNMR spectra of the selected 
compounds has been obtained from Indian 
Institute of Chemical Technology  
Hyderabad.The PMR spectra were 
recorded on  BRUKER  AVANCE  II  
300  NMR  SPECTROMETER  in  a  
mixture  of DMSO. Chemical shift 
values are reported as values in ppm 
relative to TMS (d=0) as internal 
standard. 
 
 
 
 
e)  The Mass spectrum of the selected 
synthesized compounds has been 
performed in Indian Institute of 
Chemical Technology Hyderabad. 
The FAB mass spectra were recorded 
on JEOL SX-102/DA-6000 Mass 
Spectrometer using Argon/Xenon 
(6Kv, 10Ma) as the FAB gas. 
f) Purity of compounds was checked on 
“Silica Gel G” coated on laboratory 
micro slides prepared by dipping 
method or precoated plates, eluent was 
the mixture of different polar and non-
polar  solvents in varying proportions 
and detection was done either by 
observing in UV (ultra-violet) light or 
exposure to iodine vapours as required. 
The absence of TLC spots for starting 
materials and appearance of new TLC 
spot at different Rf value ensured the 
completion of reaction. 
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EXPERIMENTAL: 
          SCHEME 
 
 
 
 
 
 
O
Cl
Benzoyl chloride
NH2
NH
X
NH2
+
X = O [Hydrazine -1-carboxamide]  (A)
X = S [Hydrazine -1-carbothioamide]  (B)
C
O
NH C
X
NH NH2
X= O [N1-Hydrazinocarbonyl benzene-1-carboxamide] (1A)
X=S [N1-Hydrazinocarbothioylbenzene-1-carboxamide](1B)
Ar-CHO
C
O
NH C
X
NH N CH Ar
-
X=O [N1-((2-((E)-1-(substituted phenyl)methylidene) hydrazino)carbonylbenzene-1-carboxamide] (2A1- A6)
X=S [N1-((2-((E)-1-(substituted phenyl)methylidene) hydrazino)carbothioylbenzene-1-carboxamide] (2B1- B6)
Hs-CH2 COOH
C
O
NH C
X
NH N
S
O
Ar
X=O [N-(2-(substituted phenyl)-4-oxo-1,3-thiozolan-3-yl)-N1-(phenylcarbonyl)urea](3A1- A6)
X=S [N-(2-(substituted phenyl)-4-oxo-1,3-yl)-N1-(henylcarbonyl)thiourea] (3B1- B6)
Mercapto acetic acid
-HCL
 
 
  
 
 
 
 
 
 
 
 
 
 
X = 0 X = S Ar 
3A1 3B1 -H 
3A2 3B2 4-NO2 
3A3 3B3 4-OCH3 
3A4 3B4 4-F 
3A5 3B5 4-Cl 
3A6 3B6 4-Br 
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SYNTHETIC STUDIES: 
In the present dissertation by the condensation of semicarbazide or thiosemicarbazide with benzoyl 
chloride, substituted thiazolidine-4-ones derivatives synthesized. The synthesis consists of three steps, 
which are as follows: 
 
Preperation of N-hydrazinocarbonylbenzene-1-carboxamide/N–hydrazinocarbothioyl benzene- 
1-carboxamide (1A and 1B): 
The mixture of Semicarbazide (0.1 mol) and Thiosemicarbazide (0.1mol) i n  benzoyl chloride (0.1 mol) 
in 75 ml of dry alcohol was refluxed for 3-4 hours. The excess of alcohol was removed by distillation 
and the contents of the flask were poured  onto  crushed ice.The product seperated was filtered,washed 
with water dried overnight and recrystallized from aqous  ethanol. The purity of all the compounds was 
established by single spot on TLC plate using silica gel G. Solvent  system used: Acetone:Benzene 
(1:1). 
 
O
Cl
Benzoyl chloride
NH2
NH
X
NH2
+
X = O [Hydrazine -1-carboxamide]  (A)
X = S [Hydrazine -1-carbothioamide]  (B)
-HCL C
O
NH C
X
NH NH2
X= O [N1-Hydrazinocarbonyl benzene-1-carboxamide] (1A)
X=S [N1-Hydrazinocarbothioylbenzene-1-carboxamide](1B)
 
 
Preperation of N
1
-((2-((E)-1-(Substituted Phenyl)methylidene)hydrazino) carbonyl benzene-1- 
carboxamide (2A1-2A6) / N
1
-((2-((E)-1-(SubstitutedPhenyl) methylidene) hydrazino)carbothioyl 
benzene-1-carboxamide (2B1-2B6): 
 
C
O
NH C
X
NH NH2
X= O (1A)
X= S (1B)
Ar- CHO C
O
NH C
X
NH N CH R
X= O (2A1- A6)
X= S (2B1 - B6)
 
 
 
To a mixture of N-hydrazinocarbonylbenzene-1-
carboxamide/-hydrazino carbothioylbenzene-1-
carboxamide ( 0.1mol) and aromatic aldehyde ( 0.1 
mol) in dry ethanol (25 ml), 2-3 drops of Conc 
H2SO4 was added and was refluxed for 3-4 hours. 
The contents are poured onto crushed. 
The solid, N
1
-((2-((E)-1-(Substituted Phenyl) 
methylidene) hydrazino) carbonylbenzene-1-
carboxamide/N
1
-((2-((E)-1-(Substituted Phenyl) 
methylidene) hydrazino) carbothioylbenzene-1-
carboxamide formed was filtered, dried and 
recrystallized from ethanol to obtain the compound 
in pure form. The purity of all the compounds was 
established by single spot on TLC plate using 
silica gel G. Solvent system used: 
Acetone:Benzene (1:1).  
 
Preparation of N-(2-(substituted phenyl)-4-oxo-
1,3-thiazolan-3-yl)-N1- (phenylcarbonyl) urea 
(3A1-3A6)/N-(2-(substitutedphenyl)-4-oxo-1,3- 
thiazolan-3-yl)-N1-(phenylcarbonyl) thiourea 
(3B1-3B6): 
To a mixture Schiff bases (0.1mol)(2A1-
2A6&2B1-2B6) obtained as above mercapto 
acetic acid (0.1) in dry benzene(75ml) was added 
slowly to the above flask Dean stark apparatus 
was set to  remove the water continuously which 
was formed during the course of reaction,then the 
reaction mixture was refluxed for 15-16 hrs and the 
excess of benzene was distilled off  to get solid 
thiazolidin-4-ones derivatives.The solid product 
was filtered, dried and recrystallised from absolute 
alcohol. The purity of all the compounds was 
established by single spot on TLC plate using 
silica gel G. 
 Solvent system used: Acetone: Benzene (1:1).  
 
BIOLOGICAL ACTIVITY: 
Antimicrobial activity[42,43]:  
In general, any compound or drug inhibits the 
growth or causes the death of microorganisms, 
known as antimicrobial agents. Any drug which 
inhibits the growth of  bacteria  or  fungi,  it  is  
said  to  possess bacteriostatic  and  fungi  static  
activity respectively. If  it  kills  the  bacteria  or  
fungi,  it  said  to  possess  bactericidal  and 
fungicidal activity. 
In- vitro tests are used as screening procedure 
for new antimicrobial agents and for testing the 
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susceptibility of individual isolates from 
infections, to determine which of the available 
drugs might be useful therapeutically. Sensitivity 
testing is done to determine the range of 
microorganisms that are susceptible to the 
compound under specified conditions. It can be 
done by disk diffusion method and Cup-plate 
method .These method are suitable for the 
organisms that grow well overnight such as most 
of the common aerobes and facultative 
anaerobes and rapidly growing fungi. Several 
forms of disk diffusion methods have been 
advocated. 
Biological evaluation involves testing of 
microbial susceptibility to chemotherapeutic   
agents.   Determination   of   antimicrobial   
effectiveness   against pathogens is  essential for 
therapy. Testing can show the efficiency of 
antimicrobial against a pathogen and give an 
estimate of proper therapeutic dose. The idea of 
the effectiveness of a chemotherapeutic agent 
against a specific pathogen can be obtained from 
t h e  m i n i m u m  i n h i b i t o r y  
c o n c e n t r a t i o n  ( MIC).   
 The  MIC  is  the  lowest concentration of the 
drug that can prevent the growth of the pathogen. 
The important factors to be controlled in the 
testing of the antimicrobial activity are as 
follows, 
1.  Type of test organism. 
2.   Temperature and time of incubation. 
3.  Composition and pH of culture. 
4.  Inoculums concentration. 
 
 EVALUATION OF ANTIBACTERIAL 
ACTIVITY: 
Antibacterial activity is determined based on 
the in vitro activity in pure cultures.  In   vitro  
susceptibility t e s t  a r e   done  by  the  cup-
plate  method.  The antibacterial activity of 
thiazolidinone derivatives was evaluated by cup-
plate method against the strains of common 
pathogens,gram-negative organisms Escherichia 
coli, Salmonella typhi Gram-positive organisms 
Staphylococcus aureus, Bacillus subtilis. 
Ciprofloxacin were used as standard drug at 
the concentration of 100 µg/ml. 
 The microorganisms used in the present 
screening were procured from the Department 
of Microbiology, Gulbarga University, Gulbarga. 
 
Test organisms (bacteria): 
Staphylococcus aureus (Gram-positive bacteria) 
Bacillus subtilis            (Gram-positive bacteria) 
Escherichia coli           (Gram-negative bacteria) 
Salmonella typhi                                             (Gram-negative bacteria) 
All the synthesized compounds were screened 
for antibacterial activity against the above-
mentioned strains by cup-plate method. 
The following materials ware used for the 
testing: 
1.  Nutrient agar 
2.  Sterilized petridishes, pipettes and   beakers 
3.  Sterilized 6 mm cork borer 
4.  18-24 hr. old growth culture in nutrient  broth. 
5.  Sterilized test t u b e s  c o n t a i n i n g      
      s o l u t i o n  o f  t e s t  c o m p o u n d s  i n  
d e s i r e d  concentration 
Preparation of Nutrient Agar medium: 
Nutrient agar media (40g), bacteriological 
peptone (1g), beef extract (5g) and sodium 
chloride (5g) were dissolved in distilled water 
(1000 ml). The pH of the solution  was  
adjusted  to  7  to  7.4  by  using  sodium  
hydroxide  solution  (40%, approximately 0.25 
ml for 100 ml of nutrient broth) and then 
sterilized for 30 min. at 15 lbs pressure in an 
autoclave. 
Preparation of sub culture: 
One day prior to test the microorganisms were 
inoculated into the sterilized nutrient broth and 
incubated at 370C for 24 hr. On the day of 
testing, the organisms ware subcultured into 
sterile nutrient broth. After incubating for 3 hr, 
the growth thus obtained was used as inoculums 
for the test. 
 
Sterilization of media and glasswares: 
The media used in the present study, nutrient 
agar and nutrient broth were sterilized in a 
conical flask of suitable capacity by autoclaving 
the same at 15 lbs pressure for 20 min. The 
cork borer , petridishes, test tubes and 
pipettes, were sterilized by employing hot air 
oven at 1600C for 1 hr. 
 
Preparation of solution of test compound: 
The test compound (5 mg each) was dissolved in 
freshly distilled DMF (5 ml) in serially labeled 
sterile test tubes, thus giving a final 
concentration of 100 µgm/0.1 ml 
 
Preparation of solution of standard compound: 
The standard compound Ciprofloxacin (5 mg 
each) was dissolved in freshly distilled  DMF  
(5  ml)  in  serially  labeled  sterile  test  tubes,  
thus  giving  a  final concentration of 100 
µgm/0.1 ml 
 
Method of testing 
The method depends on the diffusion of an 
antibiotic from a cavity through the solidified 
agar layer in a petridish to an extent such that 
growth of the added microorganisms is 
prevented entirely in a circular area or zone 
around the cavity containing a solution of test 
compound. About 15-20 ml of molten nutrient 
agar was poured into each of the sterile 
petridishes. The cups were  made by scooping 
out nutrient agar with a sterile cork borer. The 
agar plates so prepared were divided into 
different  set  and  each  set  of  the  plates  were  
inoculated  with  the  suspension  of particular 
organism by spread plate technique. 
The cups of inoculated plates were then filled 
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with 0.1 ml of the test solution; the plates were 
then incubated at 37
0
C for 24 hours. The zone 
of inhibition(diameter in mm)  developed, if 
any, was then measured for the particular 
compound with each organism. The solvent 
DMF was used as negative –control to know the 
activity of the solvent. The results of 
antibacterial testing are summarized in the 
following table no.5 
 
Antifungal activity: 
The antifungal activity of Thiazolidinones, 
derivatives were carried out by cup & plate 
method, in comparison with that of standard 
antifungal drugs, clotrimazole. The fungi culture 
used were Candida albicans and Aspergillus 
niger. 
 
MATERIAL AND METHODS: 
Cup -plate diffusion method: Antifungal activity 
of the test compounds was assessed against the 
above strains of fungi by cup plate diffusion 
method. The following materials were used: 
1.  Sabourauds agar 
2.  Sterilized Petri-dishes and pipettes of 0.1   
      ml and 0.2 ml 
3.  Cultures grown in Sabourauds broth 
       4.  Sterilized test tubes for preparation     
             of solution of the test compounds in            
           desired concentration. 
Preparation of media:  
Sabourauds agar: 
Bacteriological peptone (1 g) and glucose (4 
g) were dissolved in distilled water (100 ml) 
and filtered. Agar powder (2 g) was added and 
sterilized for 30 min. at 15lbs pressure. 
 
Preparation of sub cultures: 
One day prior to the test, inoculation of the 
microorganism (Candida Albicans & 
Aspergillus Niger) was made in sabourauds broth 
and incubated at 37
0
C for 18 hr. 
 
Sterilization of media and glasswares: 
The media used in the present study was 
sterilized in conical flask of suitable capacity by 
autoclaving at 15 lbs pressure for about 20 min. 
The cork borer, petridishes, test tubes and pipettes 
were sterilized in hot air oven at 160
0
C for one 
hour. 
 
Preparation of solution: 
1.  Clotrimazole:  5  mg  of  the  clotimazole  
was  dissolved  in  5  ml,  of  DMF 
(dimethylformamide) to get a concentration 
of 1000 µg/1 ml. 
2.  Compounds: 5 mg of each test compounds 
was dissolved in 5 ml of DMF in Serially  
and   suitably  labeled  in  sterile  test  
tubes  thus  giving  a  final concentration 
of 1000 µg/1 ml. 
 
Method of testing: Cup-plate method: This 
method depends on the diffusion of an 
antifungal agent from a cavity through the 
solidified agar layer in a petridish to an extent 
such that growth of the added microorganism is 
prevented in a circular area or zone around the 
cavity containing a solution of antifungal agent. 
A previously liquefied medium was inoculated 
appropriate to the assay with the  requisite   of  
the  suspension  of  the  microorganisms  
between  40-500C  and inoculated medium was 
poured into petridishes to give a depth of 3 to 4 
mm. Ensured that the layer of medium were 
uniform in thickness by placing the dishes on a 
leveled surface. With the help of a cork borer, 
scooped out the set agar from each petridish. 
Using  sterile  pipettes,  the  standard  and  the  
sample  solution  (0.1  ml)  of  known 
concentrations ware fed into the bored cups. 
The dishes ware left standing for 1 to 4 hrs at 
room temperature as a period of pre-
incubation diffusion. These were then 
incubated for 48 hr. at 37
0
C. The zone of 
inhibition developed, if any was then 
accurately measured in mm growth of the 
added micro-organism is prevented in circular 
area or zone around the cavity containing a 
solution of antifungal agent. 
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Fig. 1: Antibacterial activity 
 
 
 
             
 
Fig. 2: Antifungal activity 
 
Note: -denotes no activity and, 12-19 mm moderate activity, 20-25 mm good activity. 
 
 
 
RESULTS: 
 Biological activities 
In view of the wide spectrum activities of the 
condensed 4-thiazolidinone nucleus, t h e  
synthesis of heterocyclic systems was undertaken 
in which 4-thiazolidinone nucleus is linked to 
another biologically active moiety. 
The  structure  of  the  synthesized  compounds  
were  established  by  their IR,
1
HNMR and 
Mass spectral studies .All the synthesized 
compounds were evaluated for their antibacterial 
and antifungal activity at 100µ g/0.1ml 
concentration by Cup- plate method using 
ciprofloxacin and clotrimazole as standard drugs 
respectively.The results are summarised in Table-
1. 
 
 
 
 
 
 
 
 
 
 
Antimicrobial activity: 
In  the  study  of  antibacterial  and  antifungal  
activity  of  the  synthesized derivatives, the 
results showed that the compound 3A5 has 
shown maximum activity against all the 
organism followed by the compound 3A2 .The 
rest of the compounds belonging to 3A series 
also shown good  antimicrobial activity were as 
compounds belonging to  3B  series  have shown 
moderate  growth  inhibitory activities  among 
which 3B5 and 3B4 were found to be better 
compared to standard drugs. 
  
w w w . i a j p s . c o m  
 
Page 2470 
  
Table-1: Antimicrobial activity of thiazolidin-4-one derivatives 
 
 
 
 
SI.No 
 
 
 
Compound 
 
 
Conc. 
(µg/ml) 
Diameter of zone inhibition (mm) 
Bacillus 
subtilis 
Salmonella 
typhi 
ATCC-
29212 
Escherichia      
coli 
ATCC-
25923 
Staphylococcus   
aureus 
ATCC
-27853 
Aspergillus 
niger 
Candida 
albican 
1 A
1 
100 2
0 
22 2
3 
2
2 
2
2 
2
0 
2 A
2 
100 1
9 
21 2
4 
2
2 
2
3 
2
3 
3 A
3 
100 2
2 
20 2
3 
2
3 
2
1 
2
5 
4 A
4 
100 2
0 
21 2
2 
2
1 
2
2 
2
3 
5 A
5 
100 2
1 
23 2
5 
2
2 
2
3 
2
6 
6 A
6 
100 1
9 
22 2
4 
2
1 
2
2 
2
4 
7 B
1 
100 1
6 
12 1
7 
1
6 
1
5 
2
0 
8 B
2 
100 1
7 
14 1
7 
1
7 
1
8 
1
8 
9 B
3 
100 1
8 
15 1
9 
1
6 
1
9 
2
1 
10 B
4 
100 2
0 
19 1
8 
1
7 
1
5 
2
0 
11 B
5 
100 1
8 
20 2
1 
1
7 
1
9 
2
1 
12 B
6 
100 1
5 
18 2
0 
1
6 
1
9 
2
0 
13 Ciprofloxacin 100 2
3 
25 2
7 
2
5 
- - 
14 Clotrimazole 100 - - - - 2
6 
2
8 
15.   Control - - - - - - - 
 
 
 DISCUSSION 
All the synthesized compounds (3A1-3A6) 
(3B1-3B6) have been evaluated for anti-
microbial activity at 100µ g/ml concentration 
level which shown clear zone of inhibition. The  
compounds belonging to series (3A1-3A6) 
have shown promising antibacterial  and 
antifungal  activity where as  the compounds 
belonging to series (3B1-3B6) were moderate 
when compared to  that of standard 
antimicrobial agents. The  antimicrobial  activity  
data  reveals  that,  the  compounds  bearing  the  
phenyl carbonyl urea in their structure were 
found to be more potent than the phenyl carbonyl 
thiourea containing derivatives, indicating the 
influence of oxygen in enhancing the 
antimicrobial potency. 
 
SUMMARY: 
The object of the present work is to 
synthesize certain new derivatives of 
thiazolidine-4-one which has been considered as 
magic moiety and is a core structure in various  
synthetic  pharmaceuticals  displaying wide 
spectrum  of  biological activities. 
The target molecules were successfully 
synthesized in which thiazolidin-4-one nucleus is 
linked to other biologically active moieties. The 
purity of the compounds synthesized  was   
established   by  using  TLC  technique  and  the  
structures  were established by their FT-IR, 
1
HNMR and MASS spectrum. 
All  the  derivatives  synthesized  were  screened  
for  their  antibacterial  and antifungal activities. 
Among the  compounds screened for  
antimicrobial  activities, the  series  of 
compounds  which bear phenyl carbonyl urea 
in the structure have been found to possess 
potent activity; than  the other series of 
compounds which contain phenyl carbonyl 
thiourea that indicates the influence of oxygen 
over the sulphur in enhancing the antimicrobial 
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potency. 
All these  above  results  only showed that the 
thiazolidin-4-one moiety can be rich source for 
further exploitation. The thiazolidin-4-one 
moiety needs more attention and if it is 
suitably exploited by molecular modification can 
still give better lead compounds. 
 
CONCLUSION: 
All the derivatives syn thesized were 
screened for  their  an tibacterial  and 
antifungal activities. The antimicrobial activity 
shown by the compounds was inferior to that of 
standard drug,  it  is of significance. Even 
though the structural activity relationship is not 
emerging out, it may  be  predicted that the 
higher antimicrobial activity possessed by the 
compounds belonging to series (3A1 to 3A6) 
bearing phenyl carbonyl urea in their structure 
over the other series (3B1 to 3B6) which bear 
phenyl carbonyl thiourea (sulphur in presence of 
oxygen) is quite likely that the presence of 
oxygen (urea part) could be decesive factor in 
enhancing the activity. 
From  the  above  results  one  can  establish  that  
the  synthesized  substituted thiazolidinones  can 
be rich source of exploitation.Therefore, in the 
search of new generation of active compounds, 
it may worthwhile to explore the possibility in 
this area  by making or introducing different 
functional group as substitution of primary 
amine  moieties  which  may  result  in  better  
pharmacological  agents  with  higher potency. 
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